Description

This issue depicts the current landscape and the new trends in a series of developments associated with drug discovery and development, including manufacturing for optimal drug delivery, across cancer research, autoimmune diseases, and rare disorders. The technologies incorporated in this study are related to cancer stem cells for cancer therapeutics, mammalian multi-protein clusters for drug discovery, and multi-biomarkers tests for autoimmune diseases. Special emphasis has been made on  biomanufacturing capabilities for drug delivery through precision particle fabrication.

Keywords: cancer stem cells, antitumor drug, mammalian genetic model, metastatic adenocarcinoma, rheumatoid arthritis, lysosomal acid, lipase deficiency, bilateral otitis media, encapsulation, liposome, microparticle, microsphere, microcapsule, precision particle fabrication